Tara Stock Analysis Protara Therapeutics Biotech Posts 1.39 Percent Gain At 5.11 Dollar Level 20260403 1 Texas Capital Bancshares Inc Series B Preferred TCBIO Q1 2026 Earnings Preferred EPS Surpasses Estimates with 898 Surprise UK and Gulf Cooperation Council Seal Historic Trade Deal Poised to Boost Economy by Billions BCRX Q1 2026 Earnings Significant EPS Miss Amid Ongoing Operational Adjustments Civista Bancshares Q1 2026 Earnings Strong Net Interest Margin Drives EPS Beat Stock Edges Higher Meta Platforms Announces 8000 Job Cuts in Shift Toward AI Investment AG Q1 2026 Earnings EPS Misses Estimates as Silver Market Dynamics Shift GALT Q1 2026 Earnings Narrowed Loss Amid Clinical Progress Stock Rally